BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Vecuronium Bromide

A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents.

298+ PubMed studies analyzed · 66 RCTs · Evidence Score: 56

Research Domains

Vecuronium Bromide has been studied across 19 research domains including ❤️ Cardiovascular, 💪 Strength & Power, 🫁 Respiratory, 😴 Sleep, 🔬 Oncology. The primary research focus is ❤️ Cardiovascular with 13% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Vecuronium Bromide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rimantadine
2 shared targets
epinastine
2 shared targets
amantadine
2 shared targets
pantoprazole
2 shared targets
Triacetin
2 shared targets
dabigatran
2 shared targets
camostat
2 shared targets
prazosin
2 shared targets
bithionol
3 shared targets
Irinotecan
3 shared targets
Loading evidence profile...

This evidence profile for Vecuronium Bromide is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.